Mehdi H Shishehbor

Summary

Publications

  1. ncbi request reprint Renal artery stenting: indications, techniques, and devices
    P A Erwin
    Mount Sinai School of Medicine New York, NY, USA
    Minerva Cardioangiol 61:189-99. 2013
  2. ncbi request reprint High-density lipoprotein as a therapeutic target: a systematic review
    Inder M Singh
    Department of Cardiovascular Medicine, Krannert Institute of Cardiology, Indiana University Medical Center, Indianapolis, USA
    JAMA 298:786-98. 2007
  3. ncbi request reprint Inflammation: implications for understanding the heart-brain connection
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S37-41. 2007
  4. doi request reprint Association of neighborhood socioeconomic status with physical fitness in healthy young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Am Heart J 155:699-705. 2008
  5. pmc Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 101:1741-6. 2008
  6. doi request reprint Management of carotid disease in patients undergoing coronary artery bypass surgery: is it time to change our approach?
    Sridhar Venkatachalam
    Department of Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Curr Opin Cardiol 26:480-7. 2011
  7. doi request reprint Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 2:46-53. 2009
  8. doi request reprint Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195 0002, USA
    JACC Cardiovasc Interv 2:329-36. 2009
  9. doi request reprint Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    JACC Cardiovasc Interv 1:227-32. 2008
  10. ncbi request reprint Statins promote potent systemic antioxidant effects through specific inflammatory pathways
    Mehdi H Shishehbor
    Department of Cell Biology, and Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, 9500 Euclid Ave, NC10, Cleveland, Ohio 44195, USA
    Circulation 108:426-31. 2003

Detail Information

Publications59

  1. ncbi request reprint Renal artery stenting: indications, techniques, and devices
    P A Erwin
    Mount Sinai School of Medicine New York, NY, USA
    Minerva Cardioangiol 61:189-99. 2013
    ..The role of drug eluting stents is examined, as are approaches to the detection and treatment of in-stent restenosis...
  2. ncbi request reprint High-density lipoprotein as a therapeutic target: a systematic review
    Inder M Singh
    Department of Cardiovascular Medicine, Krannert Institute of Cardiology, Indiana University Medical Center, Indianapolis, USA
    JAMA 298:786-98. 2007
    ..High-density lipoprotein cholesterol (HDL-C) is a cardiovascular risk factor that is gaining substantial interest as a therapeutic target...
  3. ncbi request reprint Inflammation: implications for understanding the heart-brain connection
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S37-41. 2007
  4. doi request reprint Association of neighborhood socioeconomic status with physical fitness in healthy young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) study
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Am Heart J 155:699-705. 2008
    ..The aim of the study was to examine the extent to which neighborhood socioeconomic status (SES) is associated with impaired fitness, independent of clinical characteristics and individual-level SES...
  5. pmc Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 101:1741-6. 2008
    ..5 micromol/L (the top tertile) were associated with a sevenfold greater mortality risk. In conclusion, homocysteine and fibrinogen levels explain nearly 40% of the attributable mortality risk from CKD...
  6. doi request reprint Management of carotid disease in patients undergoing coronary artery bypass surgery: is it time to change our approach?
    Sridhar Venkatachalam
    Department of Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Curr Opin Cardiol 26:480-7. 2011
    ..This review aims to compile current evidence in this area to help plan strategies for the optimal management of coexisting severe carotid and coronary disease...
  7. doi request reprint Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 2:46-53. 2009
    ..We sought to examine the short- and long-term outcomes of blood transfusion in patients presenting with ST-segment elevation myocardial infarction (STEMI)...
  8. doi request reprint Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195 0002, USA
    JACC Cardiovasc Interv 2:329-36. 2009
    ..Our aim was to assess the incidence of all-cause mortality in patients with anemia undergoing percutaneous coronary intervention (PCI) receiving drug-eluting stents (DES) or bare-metal stents (BMS)...
  9. doi request reprint Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    JACC Cardiovasc Interv 1:227-32. 2008
    ..We sought to examine the clinical outcomes of patients treated with drug-eluting stents (DES) compared with bare-metal stents (BMS) during primary angioplasty for ST-segment elevation myocardial infarction (STEMI)...
  10. ncbi request reprint Statins promote potent systemic antioxidant effects through specific inflammatory pathways
    Mehdi H Shishehbor
    Department of Cell Biology, and Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, 9500 Euclid Ave, NC10, Cleveland, Ohio 44195, USA
    Circulation 108:426-31. 2003
    ..Whether alternative oxidative pathways are suppressed in vivo after statin administration has not yet been reported...
  11. doi request reprint Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience
    Olcay Aksoy
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 81:E1-8. 2013
    ..To determine the role of percutaneous coronary intervention (PCI) and its impact on mortality in coronary artery disease (CAD)...
  12. pmc Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis
    Inder M Singh
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Catheter Cardiovasc Interv 76:257-62. 2010
    ..We compared the long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) for treatment of bare-metal in-stent restenosis (ISR)...
  13. doi request reprint Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 52:1041-8. 2008
    ..Our purpose was to examine the incidence of all-cause mortality among drug-eluting stents (DES) and bare-metal stents (BMS) while adjusting for many confounding factors generally not considered in prior studies...
  14. doi request reprint Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators
    Stephen G Ellis
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 4:442-8. 2011
    ..This study sought to improve methodology for predicting post-percutaneous coronary intervention (PCI) mortality...
  15. ncbi request reprint In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    J Am Coll Cardiol 49:849-54. 2007
    ....
  16. doi request reprint Safety and efficacy of carotid stenting in individuals with concomitant severe carotid and aortic stenosis
    Subrata Kar
    Department of Internal Medicine, Cleveland Clinic, Ohio, USA
    EuroIntervention 6:492-7. 2010
    ..Carotid artery stenting (CAS) prior to open-heart surgery may be a useful approach to minimise the risk of neurologic events in patients undergoing aortic valve replacement (AVR)...
  17. doi request reprint Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest
    Thomas J Helton
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 80:E9-14. 2012
    ....
  18. doi request reprint Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
    Am J Cardiol 109:1087-91. 2012
    ..007). In conclusion, although overall mortality rates are similar between men and women undergoing PCI for NSTE-ACS, women <60 years old with negative biomarkers have a higher mortality than their men peers...
  19. ncbi request reprint Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio 44195, USA
    JAMA 295:784-92. 2006
    ..Lower socioeconomic status (SES) confers heightened cardiovascular risk and mortality, although the mediating pathways are unclear...
  20. ncbi request reprint Prognostic value of myeloperoxidase in patients with chest pain
    Marie Luise Brennan
    Department of Cell Biology, Cleveland Clinic Foundation, Cleveland 44195, USA
    N Engl J Med 349:1595-604. 2003
    ..Numerous lines of evidence suggest mechanistic links between myeloperoxidase and both inflammation and cardiovascular disease...
  21. ncbi request reprint Predictive value of renal resistive index in percutaneous renal interventions for atherosclerotic renal artery stenosis
    Uygar C Yuksel
    Sones Cardiac Catheterization Lab, Cleveland Clinic, Cleveland, OH, USA
    J Invasive Cardiol 24:504-9. 2012
    ..In this study, the predictive value of renal resistive index (RRI) was retrospectively analyzed in identifying the patients who may benefit from renal angioplasty and stenting...
  22. ncbi request reprint Percutaneous treatment of aortic valve stenosis
    Inder M Singh
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 75:805-12. 2008
    ..Technical and device issues are being refined, and percutaneous aortic valve replacement is showing promise in ongoing clinical trials...
  23. doi request reprint Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis
    Inder M Singh
    Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Catheter Cardiovasc Interv 75:338-42. 2010
    ..28) were also not different. This study represents the largest analysis comparing drug-eluting to bare-metal ISR. On multivariable Cox proportional hazard analyses, drug-eluting and bare-metal ISR have similar long term outcomes...
  24. pmc Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease
    Mehdi H Shishehbor
    Department of Cell Biology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Free Radic Biol Med 41:1678-83. 2006
    ....
  25. ncbi request reprint Using statins to treat inflammation in acute coronary syndromes: Are we there yet?
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Cleve Clin J Med 73:760-6. 2006
    ..In all the studies, the benefit correlated with reductions in CRP...
  26. doi request reprint Basic data related to endovascular management of peripheral arterial disease in critical limb ischemia
    Sridhar Venkatachalam
    Department of Medicine, Cleveland Clinic, Cleveland, OH, USA
    Ann Vasc Surg 26:1039-51. 2012
    ..Such evolution makes data comparison difficult. This review aims to present the available data on endovascular therapy in critical limb ischemia patients reported over the past 2 decades...
  27. doi request reprint Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting
    Bhuvnesh Aggarwal
    Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio
    J Am Coll Cardiol 62:409-15. 2013
    ..This study sought to ascertain causes of death and the incidence of percutaneous coronary intervention (PCI)-related mortality within 30 days...
  28. doi request reprint Technique and outcome of ostial common carotid artery stenting: a single centre experience
    Akin Cam
    Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
    EuroIntervention 7:1210-5. 2012
    ..Our aim was to report techniques and outcomes of our experience in percutaneous stenting of ostial common carotid artery lesions...
  29. ncbi request reprint Inflammatory and oxidative markers in atherosclerosis: relationship to outcome
    Mehdi H Shishehbor
    Department of Preventive Cardiology, Cleveland Clinic Foundation, 9500 Euclid Avenue, C51, Cleveland, OH 44195, USA
    Curr Atheroscler Rep 6:243-50. 2004
    ....
  30. doi request reprint Socioeconomic position, not race, is linked to death after cardiac surgery
    Colleen G Koch
    Department of Cardiothoracic Anesthesia, The Cleveland Clinic, Ohio 44195, USA
    Circ Cardiovasc Qual Outcomes 3:267-76. 2010
    ..However, there is a complex interplay between race, sex, and socioeconomic position (SEP). In our investigation we sought to identify which of these was the driver of risk-adjusted survival...
  31. doi request reprint Drug-eluting versus bare-metal stents for treating saphenous vein grafts
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44114, USA
    Am Heart J 158:637-43. 2009
    ..Current data show conflicting results regarding safety and efficacy of drug-eluting stents (DES) versus bare-metal stents (BMS) for treating saphenous vein grafts (SVG). Our objective was to compare DES with BMS for SVG intervention...
  32. ncbi request reprint Comparison of outcomes in patients undergoing coronary bypass of patent versus restenosed bare metal stented coronary arteries
    Mehdi H Shishehbor
    Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 96:1416-9. 2005
    ..In conclusion, survival after bypassing a patent stented coronary artery is comparable to that after bypassing a stented restenotic coronary artery...
  33. doi request reprint The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V
    Arman T Askari
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA
    Am Heart J 158:238-43. 2009
    ..Emerging data suggest that some of the benefit of renin-angiotensin-aldosterone system (RAAS) antagonism may be derived from a reduction in the incidence of these arrhythmias in the setting of acute myocardial infarction...
  34. doi request reprint Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement
    Samir R Kapadia
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Thorac Cardiovasc Surg 137:1430-5. 2009
    ..We sought to define the characteristics and outcomes of patients referred for percutaneous aortic valve replacement...
  35. ncbi request reprint Using C-reactive protein to assess cardiovascular disease risk
    Mehdi H Shishehbor
    Department of Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 70:634-40. 2003
    ....
  36. doi request reprint Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients
    Sachin S Goel
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 103:124-9. 2009
    ..In conclusion, PFOs in patients with cryptogenic CVAs are larger, have longer tunnels, and are more frequently associated with atrial septal aneurysms. This information should be considered when evaluating patients with cryptogenic CVAs...
  37. ncbi request reprint Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 97:1585-90. 2006
    ..A randomized trial comparing multivessel PCI with staged or surgical revascularization is warranted...
  38. doi request reprint Carotid stenting vs surgery: parsing the risk of stroke and MI
    Olcay Aksoy
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 77:892-902. 2010
    ..Importantly, the risk of major stroke was low with either intervention. However, the results need to be considered in the context of the impact of each procedure on stroke and MI...
  39. doi request reprint Downstream coronary effects of drug-eluting stents
    Richard A Krasuski
    Department of Cardiovascular Medicine, The Cleveland Clinic, OH 44195, USA
    Am Heart J 162:764-771.e1. 2011
    ..We sought to compare the development of de novo stenoses and need for treatment in the downstream coronary vessel of patients treated with DES or a bare-metal stent...
  40. doi request reprint Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon
    Matthew C Bunte
    Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    JACC Cardiovasc Interv 6:1-9. 2013
    ..In this review, we summarize the current evidence in support of RSD and consider unique features of several new technologies that are likely to refine the endovascular treatment of resistant hypertension...
  41. doi request reprint Contemporary management of concomitant carotid and coronary artery disease
    Sridhar Venkatachalam
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Heart 97:175-80. 2011
    ..This review examines the available data on carotid revascularisation in relation to CABG surgery to aid in the risk-benefit decision analysis in this controversial area...
  42. ncbi request reprint Association of educational status with heart rate recovery: a population-based propensity analysis
    Mehdi H Shishehbor
    Department of Internal Medicine MHS, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 113:643-9. 2002
    ..Lower educational level may be associated with automatic imbalance. We sought to assess the association of educational level with heart rate recovery...
  43. ncbi request reprint Inflammation and atherosclerosis
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195, USA
    Curr Atheroscler Rep 6:131-9. 2004
    ..The link between inflammation and atherosclerosis provides a new venue for future pharmacologic agents that may slow the progression of atherosclerosis by inhibiting inflammation...
  44. ncbi request reprint A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis
    Taral N Patel
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Eur Heart J 28:664-72. 2007
    ..Further, we will discuss the evidence for effects of high-dose statin therapy on inflammation and C-reactive protein...
  45. doi request reprint Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Am Heart J 155:1075-80. 2008
    ..The short-term and long-term safety and efficacy of paclitaxel versus sirolimus-overlapping drug-eluting stents (DES) is unknown. We sought to examine the clinical consequences of overlapping sirolimus versus paclitaxel DES...
  46. ncbi request reprint Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery
    Mehdi H Shishehbor
    Department of Internal Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Diabetes Care 27:936-41. 2004
    ..Utilizing triglyceride/HDL cholesterol concentration as a marker of insulin resistance, we sought to assess the association between insulin resistance and HRR...
  47. doi request reprint The nutcracker syndrome
    Sridhar Venkatachalam
    Department of Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Ann Vasc Surg 25:1154-64. 2011
    ..This tabular review compiles published cases in the adult population during the period between 1980 and 2009...
  48. pmc Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?
    Mehdi H Shishehbor
    National Institutes of Health CTSA KL2 Scholar, Department of Interventional Cardiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 76:37-44. 2009
    ..In absolute terms, 95 people had to be treated over 2 years to prevent one event. There was, however, a higher incidence of diabetes in the rosuvastatin group...
  49. ncbi request reprint Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease
    Mehdi H Shishehbor
    Department of Internal Medicine, Cardiovascular Imaging Center, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiol 91:1514-7, A9. 2003
  50. ncbi request reprint Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy
    Mehdi H Shishehbor
    Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    JAMA 289:1675-80. 2003
    ..Nitrotyrosine, a specific marker for protein modification by nitric oxide-derived oxidants, is enriched in human atherosclerotic lesions and low-density lipoprotein (LDL) recovered from human atheroma...
  51. ncbi request reprint Outcomes of Culprit Versus Multivessel PCI in Patients With Multivessel Coronary Artery Disease Presenting With ST-Elevation Myocardial Infarction Complicated by Shock
    Matthew A Cavender
    Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, J3 5, Cleveland, OH 44195 USA
    J Invasive Cardiol 25:218-24. 2013
    ....
  52. doi request reprint Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery
    Manjunath G Raju
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio Section of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
    Clin Cardiol 36:456-61. 2013
    ..However, there is paucity of data on the role of statins in patients undergoing intermediate-risk noncardiac, nonvascular surgery (NCNVS)...
  53. doi request reprint Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach
    Matthew C Bunte
    Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Mail code J3 5, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
    Curr Cardiol Rep 15:363. 2013
    ..These state-of-the-art advances in CLI management are reported herein with considerations for the future treatment of CLI...
  54. doi request reprint Renal denervation to treat resistant hypertension: Guarded optimism
    George Thomas
    Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic
    Cleve Clin J Med 79:501-10. 2012
    ..But although there is reason for cautious optimism, we should keep in mind that the mechanisms of hypertension are complex and multifactorial, and further study of this novel therapy and its long-term effects is needed...
  55. doi request reprint Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure
    Eiran Z Gorodeski
    Section of Heart Failure and Cardiac Transplant Medicine, Kaufman Center for Heart Failure, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Circ Heart Fail 2:320-4. 2009
    ..There are no published clinical trials comparing dobutamine with milrinone in outpatients with stage D heart failure on continuous inotropes...
  56. pmc Serum myeloperoxidase levels independently predict endothelial dysfunction in humans
    Joseph A Vita
    Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass, USA
    Circulation 110:1134-9. 2004
    ..We therefore hypothesized that circulating levels of myeloperoxidase would predict risk of endothelial dysfunction in human subjects...
  57. ncbi request reprint Antioxidant studies need a change of direction
    Mehdi H Shishehbor
    Cleve Clin J Med 71:285-8. 2004
  58. ncbi request reprint Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease
    Shui Ping Zhao
    Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China
    Circulation 110:915-20. 2004
    ..We explored the effects of xuezhikang on endothelial function and high-sensitivity C-reactive protein (hs-CRP) in patients with coronary heart disease (CHD)...
  59. doi request reprint Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran
    Alireza Esteghamati
    Endocrine Research Center, Valiasr Hospital, Tehran University of Medical Sciences, Tehran, Iran
    Am J Hypertens 21:620-6. 2008
    ..The prevalence of hypertension in the Middle East is not well defined. We examined the prevalence, awareness, treatment, and control of hypertension in Iran...